Common name
N-methylbenzamide
IUPAC name
N-methylbenzamide
SMILES
CNC(=O)c1ccccc1
Common name
N-methylbenzamide
IUPAC name
N-methylbenzamide
SMILES
CNC(=O)c1ccccc1
INCHI
InChI=1S/C8H9NO/c1-9-8(10)7-5-3-2-4-6-7/h2-6H,1H3,(H,9,10)
FORMULA
C8H9NO
Common name
N-methylbenzamide
IUPAC name
N-methylbenzamide
Molecular weight
135.163
clogP
1.374
clogS
-1.996
Frequency
0.0031
HBond Acceptor
1
HBond Donor
1
Total PolarSurface Area
29.1
Number of Rings
1
Rotatable Bond
1
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00271 | Sulpiride |
|
Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dopamine Antagonists; Antidepressive Agents; Nervous System; Psycholeptics; Benzamides; | Sulpiride is indicated for the treatment of schizophrenia. |
| FDBD00527 | Trimethobenzamide |
|
Antiemetics; Respiratory System; Aminoalkyl Ethers; Antihistamines for Systemic Use; | For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis. |
| FDBD00868 | Balsalazide |
|
Anti-Inflammatory Agents, Non-Steroidal; Gastrointestinal Agents; Alimentary Tract and Metabolism; Aminosalicylic Acid and Similar Agents; Intestinal Antiinflammatory Agents; Antidiarrheals, Intestinal Anti-Inflammatory/antiinfective Agents; | For the treatment of mildly to moderately active ulcerative colitis. |
| FDBD01041 | Flecainide |
|
Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ic; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); | Flecainide is is a class Ic antiarrhythmic agent and as such, it is used for the prevention of paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disablin. |
| FDBD01074 | Paclitaxel |
|
Antineoplastic Agents; Immunosuppressive Agents; Antineoplastic Agents, Phytogenic; Tubulin Modulators; Antineoplastic and Immunomodulating Agents; Taxanes; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; BSEP/ABCB11 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; | Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer. |
| FDBD01813 | Mersalyl |
|
Enzyme Inhibitors; Diuretics; Cardiovascular System; Low-Ceiling Diuretics, Excl. Thiazides; Mercurial Diuretics; | |
| FDBD01913 | broflanilide |
|
Insecticide | Insecticide |
| FDBD02906 | flumetover |
|
Fungicide | Fungicide |
| FDBD02954 | fluopyram |
|
Fungicide | Fungicide |
9 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4m3b_ligand_2_7.mol2 | 4m3b | 1 | -7.65 | c1(ccccc1)C(=O)NC | 10 |
| 4m3d_ligand_2_22.mol2 | 4m3d | 1 | -7.62 | c1ccc(cc1)C(=O)NC | 10 |
| 4m3e_ligand_2_15.mol2 | 4m3e | 1 | -7.53 | c1(ccccc1)C(=O)NC | 10 |
| 4tpt_ligand_2_15.mol2 | 4tpt | 1 | -7.08 | c1(ccccc1)C(=O)N(C)C | 11 |
| 3d7z_ligand_2_14.mol2 | 3d7z | 1 | -7.05 | CNC(=O)c1ccccc1 | 10 |
| 4tpt_ligand_1_4.mol2 | 4tpt | 1 | -6.96 | c1(ccccc1)C(=O)NC | 10 |
| 2zb1_ligand_2_0.mol2 | 2zb1 | 1 | -6.95 | c1(ccccc1)C(=O)NC | 10 |
172 ,
18
